Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Pharmacologic treatment of kidney stone disease.

Eisner BH, Goldfarb DS, Pareek G.

Urol Clin North Am. 2013 Feb;40(1):21-30. doi: 10.1016/j.ucl.2012.09.013. Review.

PMID:
23177632
2.

Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options.

Sfoungaristos S, Gofrit ON, Yutkin V, Pode D, Duvdevani M.

Expert Opin Pharmacother. 2015 Jun;16(8):1209-18. doi: 10.1517/14656566.2015.1037740. Epub 2015 Apr 16. Review.

PMID:
25881654
3.

Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.

Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, Kane RL, Ouellette J, Monga M.

Ann Intern Med. 2013 Apr 2;158(7):535-43. doi: 10.7326/0003-4819-158-7-201304020-00005. Review. Erratum in: Ann Intern Med. 2013 Aug 6;159(3):230-2.

PMID:
23546565
4.

Pharmacology for renal calculi.

Blair B, Fabrizio M.

Expert Opin Pharmacother. 2000 Mar;1(3):435-41. Review.

PMID:
11249528
5.

The first kidney stone.

Uribarri J, Oh MS, Carroll HJ.

Ann Intern Med. 1989 Dec 15;111(12):1006-9. Review.

PMID:
2688503
6.

Prevention of nephrolithiasis.

Pearle MS.

Curr Opin Nephrol Hypertens. 2001 Mar;10(2):203-9. Review.

PMID:
11224695
7.

Pharmacologic expulsive treatment of ureteral calculi.

Beach MA, Mauro LS.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1361-8. Epub 2006 Jul 18. Review.

PMID:
16849614
8.

[Randomized trials in the prevention of recurrent calcium oxalate stones].

Presne C, Monge M, Bataille P, el Esper N, Choukroun G, Fournier A.

Nephrologie. 2003;24(6):303-7. Review. French.

PMID:
14584297
9.

A systematic review of medical therapy to facilitate passage of ureteral calculi.

Singh A, Alter HJ, Littlepage A.

Ann Emerg Med. 2007 Nov;50(5):552-63. Epub 2007 Aug 3. Review.

PMID:
17681643
10.

Medical management of urinary stone disease.

Park S.

Expert Opin Pharmacother. 2007 Jun;8(8):1117-25. Review.

PMID:
17516875
11.

Medical therapy to facilitate the passage of stones: what is the evidence?

Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U.

Eur Urol. 2009 Sep;56(3):455-71. doi: 10.1016/j.eururo.2009.06.012. Epub 2009 Jun 21. Review.

PMID:
19560860
12.

Medical therapy of stone disease: from prevention to promotion of passage options.

Lipkin M, Shah O.

Curr Urol Rep. 2009 Jan;10(1):29-34. Review.

PMID:
19116093
13.

Evaluation of the kidney stone patient.

Asplin JR.

Semin Nephrol. 2008 Mar;28(2):99-110. doi: 10.1016/j.semnephrol.2008.01.001. Review.

PMID:
18359391
14.

Pharmacotherapy of kidney stones.

Pak CY.

Expert Opin Pharmacother. 2008 Jun;9(9):1509-18. doi: 10.1517/14656566.9.9.1509 . Review.

PMID:
18518781
15.

Medical management of common urinary calculi.

Pietrow PK, Karellas ME.

Am Fam Physician. 2006 Jul 1;74(1):86-94. Review.

16.

Recent finding and new technologies in nephrolitiasis: a review of the recent literature.

Rosa M, Usai P, Miano R, Kim FJ, Finazzi Agr├▓ E, Bove P, Micali S; International Translational Research in Uro-Sciences Team (ITRUST).

BMC Urol. 2013 Feb 16;13:10. doi: 10.1186/1471-2490-13-10. Review.

17.

Clinical practice. Calcium kidney stones.

Worcester EM, Coe FL.

N Engl J Med. 2010 Sep 2;363(10):954-63. doi: 10.1056/NEJMcp1001011. Review. No abstract available.

18.

[Functional evaluation in patients with kidney calculi].

Stojimirovi─ç B.

Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8. Review. Serbian.

PMID:
9863414
19.

Risks associated with drug treatments for kidney stones.

York NE, Borofsky MS, Lingeman JE.

Expert Opin Drug Saf. 2015;14(12):1865-77. doi: 10.1517/14740338.2015.1100604. Epub 2015 Nov 24. Review.

20.

Medical and surgical aspects of urinary stone disease.

Burns JR.

Ala J Med Sci. 1985 Jan;22(1):68-71. Review. No abstract available.

PMID:
3883830

Supplemental Content

Support Center